Sopan Pharmaceuticals Limited IPO Date Revised; Public Issue Opens from 3rd Baishakh

• Nepse Talk
• Apr 08, 2026
• 8 views

Sopan Pharmaceuticals Limited IPO Opens from 3rd Baishakh

Kathmandu, April 8 – Sopan Pharmaceuticals Limited IPO time schedule has changed. Now, the IPO will begin on 3rd Baishakh and end on 8th Baishakh, 2083.

If the issue fails to attract adequate investors, then the deadline could be further extended up to 17th Baishakh, 2083.

Previously, the plan was to initiate the IPO from 2nd Baishakh with an earlier deadline of 6th Baishakh.

Stocks will be issued by the company at a nominal value of Rs 100 each. Of the total issue made public, 34,74,900 units have been allotted for the common people.

Sopan Pharmaceuticals’ issued capital is Rs 1.71 Arba, 25% of which, i.e., 42,90,000 units, would be offered to the public. Of this:

• 4,29,000 units have been distributed for Nepalese migrants working outside the country.
• 1,71,600 units allotted for employees. 2,14,500 units allotted for mutual funds.
• The remaining 34,74,900 units are allotted to the general public.

The Sopan Pharmaceuticals Limited IPO would be handled by NMB Capital Limited. The applicants can buy a minimum of 10 units and a maximum of 11,00

The company’s issuer rating CARE-NP B- (Is) has been upgraded to CARE-NP B (Is). This implies that the risk of default is relatively high. In addition, the long-term bank facility rating of the company is CARE-NP B, whereas the short-term rating CARE-NP A4 stays constant.

Sopan Pharmaceuticals was founded in the year 2009, and the company runs a manufacturing unit in Lalitpur, producing generic drugs and cephalosporin products. Currently, the company has obtained licenses to manufacture 139 kinds of drugs and market 70 kinds of drugs.

With the new dates, investors can now apply for the IPO.

Stay tuned to NepseTalk for the latest news.